Squarepoint’s Genesis Healthcare, Inc. GEN Stock Holding History

Squarepoint’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-464,040	Closed	-$225K	–	3873
2020 Q4	$225K	Buy	464,040 +197,483	+74%	+$99.7K	﹤0.01%	2433
2020 Q3	$145K	Buy	266,557 +164,861	+162%	+$119K	﹤0.01%	2203
2020 Q2	$70K	Buy	+101,696	New	+$81.8K	﹤0.01%	2065
2019 Q2	–	Sell	-25,871	Closed	-$37K	–	2783
2019 Q1	$37K	Buy	+25,871	New	+$38.4K	﹤0.01%	2088

Other funds holding GEN

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Squarepoint's GEN Position: Q1 2021 in Review

Squarepoint sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 464,040 shares — an estimated $225K sold.

Squarepoint first reported a position in GEN in Q1 2019 and held it in 4 quarters. The position peaked at $225K in Q4 2020. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

Squarepoint reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
Squarepoint sold 464,040 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $225K.
Squarepoint first reported a position in Genesis Healthcare, Inc. in Q1 2019 and held it in 4 quarters.
Squarepoint's Genesis Healthcare, Inc. position peaked at $225K in Q4 2020.
8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.